BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 339234)

  • 1. [Synthetic substrate analog inhibitors for the study of structure-activity relationships in proteases].
    Fittkau S
    Pharmazie; 1977; 32(8-9):445-8. PubMed ID: 339234
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
    Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
    Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thermitase--a thermostable serine protease. IV. Kinetic studies on the binding of N-acyl peptide ketones as substrate analog inhibitors].
    Fittkau S; Smalla K; Pauli D
    Biomed Biochim Acta; 1984; 43(7):887-99. PubMed ID: 6393957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Active centers and the substrate specificity of miroorganism proteinases].
    Tsyperovich AS; Lysenkov NV; Kolodzeĭskaia MV
    Usp Sovrem Biol; 1974; 77(1):18-34. PubMed ID: 4619257
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of amino acids and polypeptides on the biomass autolysis process of Saccharomyces cerevisiae].
    Nekliudov AD; Fedorova NV; Il'iukhina VP; Kupov KhA; Kravchenko LV
    Prikl Biokhim Mikrobiol; 1994; 30(1):127-31. PubMed ID: 8146109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.
    Kontijevskis A; Petrovska R; Yahorava S; Komorowski J; Wikberg JE
    Bioorg Med Chem; 2009 Jul; 17(14):5229-37. PubMed ID: 19539482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bacterial proteases with a panel of fluorescent peptide substrates.
    Wildeboer D; Jeganathan F; Price RG; Abuknesha RA
    Anal Biochem; 2009 Jan; 384(2):321-8. PubMed ID: 18957278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on serum leucyl glycyl glycine hydrolyzing enzyme in cancer. II].
    Shimizu T
    Naika Hokan; 1971 Feb; 18(2):51-8. PubMed ID: 5103266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various physico-chemical and kinetic properties of metalloproteinase from bacteriolytic lysoamidase preparation].
    Krupianko VI; Severin AI; Kudriavtseva AI; Valiakhmetov AIa; Kozlovskiĭ AG; Kulaev IS
    Biokhimiia; 1990 Jul; 55(7):1279-86. PubMed ID: 2223903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and prospective applications of non-proteinogenic amino acids in profiling of proteases substrate specificity.
    Kasperkiewicz P; Gajda AD; Drąg M
    Biol Chem; 2012 Sep; 393(9):843-51. PubMed ID: 22944686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
    Flipo M; Beghyn T; Charton J; Leroux VA; Deprez BP; Deprez-Poulain RF
    Bioorg Med Chem; 2007 Jan; 15(1):63-76. PubMed ID: 17070058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel fluoropeptidomimetics as potential mimics of the transition state during peptide hydrolysis.
    Annedi SC; Li W; Samson S; Kotra LP
    J Org Chem; 2003 Feb; 68(3):1043-9. PubMed ID: 12558433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.
    Smyth TP
    Bioorg Med Chem; 2004 Aug; 12(15):4081-8. PubMed ID: 15246086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid qualitative protease microassay (RPM).
    Mohan S; Ma PW; Luthe DS
    J Biochem Biophys Methods; 2005 Sep; 64(3):182-8. PubMed ID: 16112198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogenic ester substrates to assess proteolytic activity.
    Mugherli L; Burchak ON; Chatelain F; Balakirev MY
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4488-91. PubMed ID: 16806926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly and selective "in synthesis" labeling of quenched fluorogenic protease substrates.
    Chersi A; Ferracuti S; Falasca G; Butler RH; Fruci D
    Anal Biochem; 2006 Oct; 357(2):194-9. PubMed ID: 16930525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional determinants of the Epstein-Barr virus protease.
    Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
    J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
    Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of a calcium-activated protease in squid axoplasm which selectively degrades neurofilament proteins.
    Pant HC; Gainer H
    J Neurobiol; 1980; 11(1):1-12. PubMed ID: 6986451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Affinity chromatography of aminopeptidases].
    Kolodzeĭskaia MV
    Ukr Biokhim Zh (1978); 1983; 55(5):577-91. PubMed ID: 6356542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.